Erratum: Specificity of incident diagnostic outcomes in patients at clinical high risk for psychosis (Schizophrenia Bulletin (2015) 41 (1066-1075) DOI: 10.1093/schbul/sbv091);Specificity of incident diagnostic outcomes in patients at clinical high risk for psychosis

Schizophrenia Bulletin

Volumn 41, Issue 5, 2015, Pages 1066-1075

  Webb, Jadon R ^a   Addington, Jean ^b   Perkins, Diana O ^c   Bearden, Carrie E ^d   Cadenhead, Kristin S ^e   Cannon, Tyrone D ^f   Cornblatt, Barbara A ^g   Heinssen, Robert K ^h   Seidman, Larry J ⁱ   Tarbox, Sarah I ^j   Tsuang, Ming T ^e,i   Walker, Elaine F ^k   McGlashan, Thomas H ^j   Woods, Scott W ^j  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f YALE UNIVERSITY   (United States)

^g ZUCKER HILLSIDE HOSPITAL   (United States)

^h NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j Yale University School of Medicine   (United States)

^k EMORY UNIVERSITY   (United States)

more..

Author keywords

Anxiety disorder; Bipolar disorder; Nonbipolar mood disorder; Validity

Indexed keywords

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DSM-IV; FEMALE; HELP SEEKING BEHAVIOR; HIGH RISK PATIENT; HUMAN; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOSIS; SENSITIVITY ANALYSIS; AFFECTIVE DISORDERS, PSYCHOTIC; ANXIETY DISORDERS; CLASSIFICATION; CLINICAL TRIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FOLLOW UP; INCIDENCE; MOOD DISORDERS; MULTICENTER STUDY; PATIENT ATTITUDE; PRODROMAL SYMPTOM; PSYCHOTIC DISORDERS; RISK; SENSITIVITY AND SPECIFICITY; SYNDROME; YOUNG ADULT;

ADOLESCENT; ADULT; AFFECTIVE DISORDERS, PSYCHOTIC; ANXIETY DISORDERS; BIPOLAR DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MOOD DISORDERS; PATIENT ACCEPTANCE OF HEALTH CARE; PRODROMAL SYMPTOMS; PSYCHOTIC DISORDERS; RISK; SENSITIVITY AND SPECIFICITY; SYNDROME; YOUNG ADULT;

EID: 84943172455     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbx097     Document Type: Erratum

References (81)

1. Huber G, Gross G. The concept of basic symptoms in schizophrenic and schizoaffective psychoses. Recenti Prog Med. 1989;80:646-652.
2. Kane JM, Rifkin A, Quitkin F, Nayak D, Ramos-Lorenzi J. Fluphenazine vs placebo in patients with remitted, acute first-episode schizophrenia. Arch Gen Psychiatry. 1982;39:70-73.
3. Falloon IRH. Early intervention for first episodes of schizophrenia: a preliminary exploration. Psychiatry. 1992;55:4-15.
4. McGlashan TH. Early detection and intervention in schizophrenia: research. Schizophr Bull. 1996;22:327-345.
5. Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar A. Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull. 1996;22:283-303.
6. Woods SW, Miller TJ, McGlashan TH. The "prodromal" patient: both symptomatic and at-risk. CNS Spectr. 2001;6:223-232.
7. Perkins DO, Gu H, Boteva K, Lieberman JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry. 2005;162:1785-1804.
8. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry. 2005;62:975-983.
9. Larsen TK, Melle I, Auestad B, et al. Early detection of psychosis: positive effects on 5-year outcome. Psychol Med. 2011;41:1461-1469.
10. Stafford MR, Jackson H, Mayo-Wilson E, Morrison AP, Kendall T. Early interventions to prevent psychosis: systematic review and meta-analysis. BMJ. 2013;346:f185.
11. Marshall M, Rathbone J. Early intervention for psychosis. Cochrane Database Syst Rev. 2011;6:CD004718.
12. Fusar-Poli P, Borgwardt S, Bechdolf A, et al. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry. 2013;70:107-120.
13. McGlashan TH, Walsh BC, Woods SW. The Psychosis-Risk Syndrome: Handbook for Diagnosis and Follow-up. New York, NY: Oxford University Press; 2010.
14. Yung A, Phillips L, McGorry PD. Treating Schizophrenia in the Prodromal Phase: Back to the Future. London: Taylor & Francis; 2004.
15. Schultze-Lutter F, Michel C, Ruhrmann S, Schimmelmann BG. Prevalence and clinical significance of DSM-5-attenuated psychosis syndrome in adolescents and young adults in the general population: the Bern Epidemiological At-Risk (BEAR) study. Schizophr Bull. 2014;40:1499-1508.
16. Fusar-Poli P, Bonoldi I, Yung AR, et al. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry. 2012;69:220-229.
17. Fusar-Poli P, Carpenter WT, Woods SW, McGlashan TH. Attenuated Psychosis Syndrome: Ready for DSM-5.1? Annu Rev Clin Psychol. 2014;10:155-192.
18. Fusar-Poli P, Yung AR, McGorry P, van Os J. Lessons learned from the psychosis high-risk state: towards a general staging model of prodromal intervention. Psychol Med. 2014;44:17-24.
19. McGorry P, van Os J. Redeeming diagnosis in psychiatry: timing versus specificity. Lancet. 2013;381:343-345.
20. Salokangas RK, Ruhrmann S, von Reventlow HG, et al.; EPOS group. Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: prospective follow-up of 245 clinical high-risk outpatients in four countries. Schizophr Res. 2012;138:192-197.
21. Fusar-Poli P, Nelson B, Valmaggia L, Yung AR, McGuire PK. Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis. Schizophr Bull. 2014;40:120-131.
22. Svirskis T, Korkeila J, Heinimaa M, et al. Axis-I disorders and vulnerability to psychosis. Schizophr Res. 2005;75:439-446.
23. Rosen JL, Miller TJ, D'Andrea JT, McGlashan TH, Woods SW. Comorbid diagnoses in patients meeting criteria for the schizophrenia prodrome. Schizophr Res. 2006;85:124-131.
24. Lencz T, Smith CW, Auther A, Correll CU, Cornblatt B. Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia. Schizophr Res. 2004;68:37-48.
25. Woods SW, Addington J, Cadenhead KS, et al. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull. 2009;35:894-908.
26. Modinos G, Allen P, Frascarelli M, et al. Are we really mapping psychosis risk? Neuroanatomical signature of affective disorders in subjects at ultra high risk. Psychol Med. 2014;44:3491-3501.
27. Lin A, Wood SJ, Nelson B, Beavan A, McGorry P, Yung AR. Outcomes of nontransitioned cases in a sample at ultra-high risk for psychosis. Am J Psychiatry. 2015;172:249-258.
28. Fusar-Poli P, Cappucciati M, Rutigliano G, et al. At risk or not at risk? Meta-analysis of the prognostic accuracy of psychometric interviews for psychosis prediction. World Psychiatry. In press.
29. Addington J, Cadenhead KS, Cornblatt BA, et al. North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment. Schizophr Res. 2012;142:77-82.
30. Addington J, Cadenhead KS, Cannon TD, et al.; North American Prodrome Longitudinal Study. North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull. 2007;33:665-672.
31. Addington J, Penn D, Woods SW, Addington D, Perkins DO. Facial affect recognition in individuals at clinical high risk for psychosis. Br J Psychiatry. 2008;192:67-68.
32. Miller TJ, McGlashan TH, Rosen JL, et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry. 2002;159:863-865.
33. Miller TJ, McGlashan TH, Rosen JL, et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull. 2003;29:703-715.
34. Lencz T, Smith CW, Auther A, Correll CU, Cornblatt B. Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia. Schizophr Res. 2004;68:37-48.
35. Jung MH, Jang JH, Kang DH, et al. The reliability and validity of the korean version of the structured interview for prodromal syndrome. Psychiatry Investig. 2010;7:257-263.
36. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition, January 1995 FINAL, (SCID-I/P Version 2.0). New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1995.
37. Kaufman J, Birmaher B, Brent D, et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36:980-988.
38. Andreasen NC, Flaum M, Arndt S. The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry. 1992;49:615-623.
39. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition, (SCID-I/NP Version 2.0). New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 2002.
40. Walker EF, Cornblatt BA, Addington J, et al. The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: a naturalistic study of the North American Prodrome Longitudinal Sample. Schizophr Res. 2009;115:50-57.
41. Cadenhead KS, Addington J, Cannon T, et al. Treatment history in the psychosis prodrome: characteristics of the North American Prodrome Longitudinal Study Cohort. Early Interv Psychiatry. 2010;4:220-226.
42. Woods SW, Addington J, Bearden CE, et al. Psychotropic medication use in youth at high risk for psychosis: comparison of baseline data from two research cohorts 1998-2005 and 2008-2011. Schizophr Res. 2013;148:99-104.
43. Hall RC. Global assessment of functioning. A modified scale. Psychosomatics. 1995;36:267-275.
44. Kaymaz N, Drukker M, Lieb R, et al. Do subthreshold psychotic experiences predict clinical outcomes in unselected non-help-seeking population-based samples? A systematic review and meta-analysis, enriched with new results. Psychol Med. 2012;42:2239-2253.
45. Breslau N, Roth T, Rosenthal L, Andreski P. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry. 1996;39:411-418.
46. Costello EJ, Mustillo S, Erkanli A, Keeler G, Angold A. Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry. 2003;60:837-844.
47. Lewinsohn PM, Hops H, Roberts RE, Seeley JR, Andrews JA. Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students. J Abnorm Psychol. 1993;102:133-144.
48. Lewinsohn PM, Seeley JR, Buckley ME, Klein DN. Bipolar disorder in adolescence and young adulthood. Child Adolesc Psychiatr Clin N Am. 2002;11:461-475.
49. Newman DL, Moffitt TE, Caspi A, Magdol L, Silva PA, Stanton WR. Psychiatric disorder in a birth cohort of young adults: prevalence, comorbidity, clinical significance, and new case incidence from ages 11 to 21. J Consult Clin Psychol. 1996;64:552-562.
50. Roberts RE, Roberts CR, Chan W. One-year incidence of psychiatric disorders and associated risk factors among adolescents in the community. J Child Psychol Psychiatry. 2009;50:405-415.
51. Ströhle A, Höfler M, Pfister H, et al. Physical activity and prevalence and incidence of mental disorders in adolescents and young adults. Psychol Med. 2007;37:1657-1666.
52. Oldehinkel AJ, Wittchen HU, Schuster P. Prevalence, 20-month incidence and outcome of unipolar depressive disorders in a community sample of adolescents. Psychol Med. 1999;29:655-668.
53. Jonsson U, Bohman H, von Knorring L, Olsson G, Paaren A, von Knorring AL. Mental health outcome of long-term and episodic adolescent depression: 15-year follow-up of a community sample. J Affect Disord. 2011;130:395-404.
54. Wittchen HU, Nocon A, Beesdo K, et al. Agoraphobia and panic. Prospective-longitudinal relations suggest a rethinking of diagnostic concepts. Psychother Psychosom. 2008;77:147-157.
55. Fergusson DM, Horwood LJ, Ridder EM, Beautrais AL. Subthreshold depression in adolescence and mental health outcomes in adulthood. Arch Gen Psychiatry. 2005;62:66-72.
56. Klein DN, Shankman SA, Lewinsohn PM, Seeley JR. Subthreshold depressive disorder in adolescents: predictors of escalation to full-syndrome depressive disorders. J Am Acad Child Adolesc Psychiatry. 2009;48:703-710.
57. Clarke GN, Hawkins W, Murphy M, Sheeber LB, Lewinsohn PM, Seeley JR. Targeted prevention of unipolar depressive disorder in an at-risk sample of high school adolescents: a randomized trial of a group cognitive intervention. J Am Acad Child Adolesc Psychiatry. 1995;34:312-321.
58. Clarke GN, Hornbrook M, Lynch F, et al. A randomized trial of a group cognitive intervention for preventing depression in adolescent offspring of depressed parents. Arch Gen Psychiatry. 2001;58:1127-1134.
59. Gillham JE, Hamilton J, Freres DR, Patton K, Gallop R. Preventing depression among early adolescents in the primary care setting: a randomized controlled study of the Penn Resiliency Program. J Abnorm Child Psychol. 2006;34:203-219.
60. Young JF, Mufson L, Davies M. Efficacy of interpersonal psychotherapy-adolescent skills training: an indicated preventive intervention for depression. J Child Psychol Psychiatry. 2006;47:1254-1262.
61. Compas BE, Forehand R, Keller G, et al. Randomized controlled trial of a family cognitive-behavioral preventive intervention for children of depressed parents. J Consult Clin Psychol. 2009;77:1007-1020.
62. Rohde P, Stice E, Shaw H, Gau JM. Effectiveness trial of an indicated cognitive-behavioral group adolescent depression prevention program versus bibliotherapy and brochure control at 1- and 2-year follow-up. J Consult Clin Psychol. In press.
63. Rohde P, Stice E, Gau JM. Effects of three depression prevention interventions on risk for depressive disorder onset in the context of depression risk factors. Prev Sci. 2012;13:584-593.
64. Arnarson EO, Craighead WE. Prevention of depression among Icelandic adolescents. Behav Res Ther. 2009;47:577-585.
65. Garber J, Clarke GN, Weersing VR, et al. Prevention of depression in at-risk adolescents: a randomized controlled trial. JAMA. 2009;301:2215-2224.
66. Vázquez FL, Torres A, Blanco V, Díaz O, Otero P, Hermida E. Comparison of relaxation training with a cognitive-behavioural intervention for indicated prevention of depression in university students: a randomized controlled trial. J Psychiatr Res. 2012;46:1456-1463.
67. Seligman ME, Schulman P, Tryon AM. Group prevention of depression and anxiety symptoms. Behav Res Ther. 2007;45:1111-1126.
68. Dadds MR, Spence SH, Holland DE, Barrett PM, Laurens KR. Prevention and early intervention for anxiety disorders: a controlled trial. J Consult Clin Psychol. 1997;65:627-635.
69. Seligman MEP, Schulman P, DeRubeis RJ. The prevention of depression and anxiety. Prev Treat. 1999;2:1-22.
70. Feldner MT, Zvolensky MJ, Schmidt NB. Prevention of anxiety psychopathology: a critical review of the empirical literature. Clin Psychol Sci Prac. 2004;11:405-24.
71. Gardenswartz CA, Craske MG. Prevention of panic disorder. Behav Ther. 2001;32:725-37.
72. Hunt C, Andrews G, Crino R, Erskine A, Sakashita C. Randomized controlled trial of an early intervention programme for adolescent anxiety disorders. Aust N Z J Psychiatry. 2009;43:300-304.
73. Christensen H, Batterham P, Mackinnon A, et al. Prevention of generalized anxiety disorder using a web intervention, iChill: randomized controlled trial. J Med Internet Res. 2014;16:e199.
74. Fusar-Poli P, Meneghelli A, Valmaggia L, et al. Duration of untreated prodromal symptoms and 12-month functional outcome of individuals at risk of psychosis. Br J Psychiatry. 2009;194:181-182.
75. Nelson B, Yuen HP, Wood SJ, et al. Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study. JAMA Psychiatry. 2013;70:793-802.
76. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, Publishers; 1988.
77. Schultze-Lutter F, Schimmelmann BG, Ruhrmann S, Michel C. 'A rose is a rose is a rose', but at-risk criteria differ. Psychopathology. 2013;46:75-87.
78. Woods SW, Walsh BC, Addington J, et al. Current status specifiers for patients at clinical high risk for psychosis. Schizophr Res. 2014;158:69-75.
79. McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry. 2006;40:616-622.
80. Cross SP, Hermens DF, Scott EM, Ottavio A, McGorry PD, Hickie IB. A clinical staging model for early intervention youth mental health services. Psychiatr Serv. 2014;65:939-943.
81. Hickie IB, Scott EM, Hermens DF, et al. Applying clinical staging to young people who present for mental health care. Early Interv Psychiatry. 2013;7:31-43.